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The purpose of the meta-analysis of randomized trials was to analyze the significance of
ethnicity on the effect of sodium reduction (SR) on blood pressure (BP) by estimating the
effect of SR on BP in Asians, Blacks and Whites under conditions, which were adjusted
with respect to baseline BP, baseline sodium intake and quantity of SR. Relevant studies
were retrieved from a pool of 167 RCTs published in the period 1973–2010 and identified
in a previous Cochrane review. 9 Asian, 9 Black, and 74 White populations standardized
with respect to the range of baseline blood pressure, the range of baseline sodium,
duration of SR (at least 7 days) and baseline sodium intake (at maximum 250mmol) intake
were included. In the cross-sectional analysis, there was no difference in change in SBP
to SR between the ethnic groups, but there was a small difference in SR induced change
in DBP between Blacks and Whites (p = 0.04). The comparison of changes in SBP
and DBP to SR in ethnic groups compared in identical studies showed no statistically
significant differences between the groups.
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Introduction
The effect of sodium reduction (SR) on blood pressure (BP) is smaller in persons with normal blood
pressure than in hypertensive persons (Graudal et al., 1998, 2011). A recent dose-response analysis
showed a dose-response relationship between SR and effect on BP in study populations with amean
BP above 130/80mmHg, but not in study populations with a mean BP below 130/80mmHg, unless
SR was applied on study populations with an extreme sodium intake above about 6 g sodium (14.5 g
salt) (Graudal et al., 2015). These findings indicate that the effect of SR depends on the baseline
blood pressure, the baseline sodium intake and the quantity of SR. Hypothetically, the duration of
SR could also be an important determinant of the effect of SR on BP, but a detailed analysis of 15
longitudinal RCTs, which investigated participants repeatedly during up to 6 weeks, showed that
the effect of SR on BP was similar during the observation period from 1 to 6 weeks indicating that
the duration of SR beyond 1 week does not influence the effect of SR on BP (Graudal et al., 2015).
Our previousmeta-analysis showed that the effect of SR on SBPwas higher in Asian hypertensive
persons (10.2mmHg) than in White (5.5mmHg) and Black hypertensive persons (6.4mmHg)
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(Graudal et al., 1998). Furthermore the effect of SR on SBP
was higher in Black persons with a normal blood pressure
(4.0mmHg) than in Asian (1.3mmHg) and White persons with
a normal BP (1.3mmHg) (Graudal et al., 1998). However, a
subsequent analysis of Blacks showed that the difference between
Blacks and Whites was small, if studies investigating extreme
sodium reductions were eliminated (Graudal and Alderman,
2014). The reason for ethnic differences are not defined and could
be due to different baseline blood pressures, sodium intakes and
doses of SR or other confounders, rather than genetic differences.
The purpose of the present supplementary analysis of our
previous meta-analysis of randomized trials (Graudal et al., 2011)
was to analyze the significance of ethnicity on the effect of SR on
BP by estimating the effect of SR on BP in Asians, Blacks and
Whites under conditions, which were adjusted with respect to
baseline BP, baseline sodium intake and quantity of SR.
Material
Relevant studies were retrieved from a pool of 167 RCTs
published in the period 1973–2010 and identified in a Cochrane
review in 2011 (Graudal et al., 2011). Search methods for
identification of these 167 studies are previously described in
detail (Graudal et al., 2011).
Methods
Eligibility Criteria
Trials randomizing participants to two different sodium intakes
were included provided that the sodium intake was measured
as 24-h urinary excretion (Graudal et al., 2011). Baseline BP
was used to define the study groups to ensure that the baseline
BP was similar across the three ethnic study groups. The most
extreme sodium intake in the world’s populations is about 6 g
sodium (14.5 g salt) (McCarron et al., 2013; Powles et al., 2013),
corresponding to about 250mmol, and we therefore excluded
studies with sodium intakes above this level, as such intakes
reflected an experimental situation rather than a population
norm. In a series of longitudinal RCTs we have showed that
the effect of SR on BP is at maximum after 1 week (Graudal
et al., 2015). As we do not know whether this effect is reached
before 1 week, we excluded studies with a shorter duration than 1
week.
In order to avoid excluding the relatively few studies, which
have been performed in Blacks and Asians, the baseline systolic
BP (SBP) range of these study groups were used to define the
baseline SBP range of the white comparator study groups.
Bias
The following factors were analyzed across the defined ethnic
groups to evaluate the comparability of the groups: Age, baseline
SBP, baseline diastolic BP (DBP), baseline sodium intake and the
quantity of sodium reduction.
Statistical Analysis
In this re-analysis featuring improved control for blood pressure
and the extent of salt intake and salt reduction the individual
study data were integrated inmeta-analyses separately for Asians,
Blacks, and Whites, and the integrated summary data for each
of the groups were then compared versus each other. As well
the separate meta-analyses as the comparisons of the summary
data for each ethnic group were performed by means of the
inverse variance method (continuous data) in Review Manager
(RevMan) [Computer program], version 5.1. Copenhagen:
The Nordic Cochrane Centre, the Cochrane Collaboration,
2008.
A supplementary meta-regression analysis of Ethnicity versus
effect on blood pressure (separate analyses for SBP and DBP)
adjusted for amount of sodium reduction, baseline blood
pressure (SBP and DBP), age, and the duration of the sodium
reduction intervention was performed by means of the multiple
regression analysis package in Statview 5.0.
Results
Study Selection
The study groups were defined from 167 references (Graudal
et al., 2011). Some references reported separate data on
sodium sensitive and sodium resistant participants. These were
integrated before inclusion in the meta-analysis. Some references
included separate analyses on hypertensive and normotensive
persons or on different ethnic groups. These were included as
separate data. The total number of study groups in the 167
references (Graudal et al., 2011) was 184. 16 study groups of
mixed ethnic populations were excluded. Two Black populations
with duration of sodium reduction less than 7 days were
excluded. As it was the objective to match studies for each ethnic
group according to range of SBP, all Asian and Black populations
were ranked with respect to baseline SBP. Ten Asian study
populations had a mean baseline SBP in the range 113–158mm
Hg and 12 Black populations had mean baseline SBP in the range
of 108–156mmHg. We excluded the one study with the lowest
baseline SBP of 108mmHg, as this was outside the 113–158
range defined by the Asian populations. In this study SBP raised
0.5mmHg when sodium intake was reduced. The remaining 11
studies had a baseline SBP range of 113–156mmHg and thus
were comparable to the Asian population concerning this range.
As SBP in the 144 studies of white populations varied in the
range of 105–179mmHg, 15 with baseline SBP above 158mmhg
and 18 with a baseline SBP in the range of 105–112mmHg were
excluded. Five white study populations with no information on
baseline SBP were also excluded, leaving 106 study populations
with a baseline SBP in the range of 113–158. Then 1 study
of Asians, 2 studies of blacks and 21 studies of whites with a
high sodium intake above 250mmol and 11 white populations
with duration of SR less than 7 days were excluded. Thus, 9
Asian populations (6 references, Table 1), 9 black populations
(7 references, Table 1) and 74 white populations (70 references,
Table 1) standardized with respect to the range of baseline blood
pressure, duration of SR (at least 7 days) and baseline sodium
intake (at maximum 250mmol) were included.
Table 1 shows the references, baseline characteristics and the
individual study data of the 9 Asian, 9 Black, and 74 White
populations included in the present study. Summary measures
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TABLE 1 | Baseline data, blood pressure outcome data and references of included studies.
Eth. Authors Dur. BP N Age HS LS B SBP B DBP E SBP SSE E DBP DSE References
A Ishimitsu 7 N 7 53 217 22 116 77 −2.0 4.3 −2.0 3.6 Clin. Sci. 1996; 91, 293–298.
A Ishimitsu 7 H 23 55 217 24 157 95 −15.7 6.0 −5.5 3.2 Clin. Sci. 1996; 91, 293–298.
A Uzu 7 H 70 51 204 31 154 94 −15.6 7.4 −5.0 3.1 AJH 1999; 12, 35–39.
A Suzuki 7 H 20 59 167 51 157 92 −4.0 2.0 −2.6 1.3 Hypertension 2000; 35,
864–868.
A Nakamura 42 N 38 47 240 216 113 66 2.0 2.0 −5.5 3.0 Circ. J. 2003;67, 530–534.
A Nakamura 42 TH 26 47 240 216 140 90 −5.8 4.9 −1.3 3.3 Circ. J. 2003;67, 530–534.
A Takahashi 365 N 341 56 248 209 123 74 −2.3 1.2 −1.2 1.0 J. Hypertens. 2006; 24, 451–8.
A Takahashi 365 TH 107 56 248 209 143 83 −5.2 2.4 0.1 1.7 J. Hypertens. 2006; 24,
451–458.
A He 42 H 29 47 176 108 142 92 −5.4 1.9 −2.2 1.0 Hypertension 2009; 54,
482–488.
B Dubbert 90 TH 67 61 194 160 138 86 −1.4 3.8 −0.5 1.7 Behav. Ther. 1995; 26, 721–732.
B Sacks 30 N 68 48 141 64 129 84 −6.4 1.2 −4.0 0.8 NEJM 2001; 344, 3–10.
B Sacks 30 H 46 48 141 64 143 89 −8.6 1.2 −5.3 0.8 NEJM 2001;344:3-10.
B Appel 105 TH 142 66 145 116 128 71 −5.0 1.7 −2.9 1.2 Arch. IM 2001; 161, 685–693.
B Palacios 21 N 15 12 109 35 113 59 3.4 1.5 −0.1 1.9 JCEM 2004; 89, 1858–1863.
B Forrester (Ni) 21 N 58 47 127 53 115 73 −4.8 1.5 −3.2 1.0 J. Hum. Hypertens. 2005; 19,
55–60.
B Forrester (Ja) 21 N 56 41 155 68 126 76 −5.1 1.5 −2.2 1.5 J. Hum. Hypertens. 2005; 19,
55–60.
B Swift 28 H 40 50 167 89 156 100 −8.0 2.1 −3.0 1.1 Hypertension 2005; 46,
308–312.
B He 42 H 69 50 165 121 149 90 −4.8 1.2 −2.2 0.7 Hypertension 2009; 54,
482–488.
W Skrabal 14 N 20 23 200 50 125 73 −2.7 2.1 −3.0 1.5 Lancet 1981; II, 895–900.
W Ambrosioni 42 H 25 23 120 60 130 75 −2.2 1.6 −0.4 1.2 Hypertension 1982; 4, 789–794.
W Beard 84 TH 90 49 161 37 141 87 −5.2 4.9 −3.4 2.9 Lancet. 1982; II, 455–458.
W Puska 72 N 38 40 167 77 131 82 −1.5 4.5 −2.1 2.8 Lancet 1983; I, 1–5.
W Puska H 72 H 34 40 167 77 147 98 1.8 5.6 0.5 3.1 Lancet 1983; I, 1–5.
W Watt 28 H 18 52 143 87 150 91 −0.5 1.5 −0.3 0.8 BMJ 1983; 286, 432–6.
W Skrabal 14 N 52 23 194 38 121 64 −3.1 4.4 −1.9 2.6 Hypertension 1984; 6, 152–158.
W Fagerberg 63 H 30 51 195 96 149 98 −3.7 7.1 −3.1 4.1 BMJ 1984; 288, 11–14.
W Maxwell 84 H 30 47 200 39 148 98 −2.0 6.7 2.0 3.8 Arch. IM 1984; 144, 1581–1584.
W Richards 28 H 12 36 180 80 137 86 −4.0 2.8 −3.0 2.3 Lancet 1984; I, 757–761.
W Tuthill 56 N 191 16 126 65 113 70 0.0 1.1 0.0 1.3 Tox. Ind. Health 1985; 1, 35–43.
W Skrabal 14 N 62 23 194 40 120 64 −3.1 2.2 −1.5 0.9 SJCLI 1985; 176(S), 47–57.
W Teow 14 N 9 25 240 40 114 66 −0.6 1.2 −2.7 1.4 Clin. Exp. Hypertens. 1986; A7,
1681–1695.
W ANHMRC 84 H 100 53 150 80 150 94 −4.8 3.9 −4.2 1.9 J. Hypertens. Suppl. 1986; 4,
S629-S637.
W Fuchs 9 N 17 20 241 12 117 57 −3.6 2.2 1.9 1.0 Braz. J. Med. Biol. Res. 1987;
20, 25–34.
W Morgan 60 TH 20 61 135 78 143 82 −6.0 9.0 −4.0 4.3 Lancet 1987; I, 227–230.
W Grobee 42 H 40 24 129 57 143 78 −0.8 1.5 −0.8 1.4 BMJ 1987; 293, 27–29.
W McGregor 30 TH 15 52 183 83 150 97 −13.0 3.3 −9.0 3.1 BMJ 1987; 294, 531–534.
W Morgan 14 H 8 63 135 68 149 96 −7.0 3.0 −6.0 3.0 J. Hypertens. 1988; 6(Suppl. 4),
S652–S654.
W Sudhir 12 N 6 35 163 29 129 81 −7.9 3.4 −5.0 2.1 Clin. Sci. 1989; 77, 605–610.
W Hargreaves 14 N 8 23 155 49 129 66 −6.0 2.2 −3.0 2.0 Clin. Sci. 1989; 76, 553–557.
W ANHMRC 48 H 103 58 153 90 154 95 −5.5 1.5 −2.8 0.8 Lancet 1989; 1, 399–402.
W Schmid 7 N 9 32 210 20 125 75 −3.0 1.9 3.0 1.6 J. Hypertens. 1990; 8, 277–283.
(Continued)
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TABLE 1 | Continued
Eth. Authors Dur. BP N Age HS LS B SBP B DBP E SBP SSE E DBP DSE References
W Schmid H 7 H 9 36 210 29 147 93 −6.0 3.1 −1.9 2.1 J. Hypertens. 1990; 8, 277–283.
W Sharma 7 N 40 25 239 25 113 71 −2.1 1.1 −3.1 1.0 Hypertension 1990; 16,
407–413.
W Friberg 13 N 10 33 152 35 114 69 0.0 2.0 −1.0 2.0 Hypertension 1990; 16,
121–130.
W Del Rio 14 H 15 49 190 90 149 94 −3.4 2.0 −1.1 1.8 Rev. Clin. Esp. 1990; 186, 5–10.
W Parker 28 TH 59 52 142 69 138 85 1.3 2.2 0.6 0.9 Hypertension 1990; 16,
398–406.
W Howe 28 N 90 13 179 98 115 60 −1.0 0.7 −0.6 0.7 J. Hypertens. 1991; 9, 181–186.
W Mascioli 28 N 48 52 179 109 131 84 −3.6 0.9 −2.3 0.8 Hypertension 1991; 17(Suppl. 1),
I21–I26.
W Egan H 7 H 18 35 214 20 124 78 −2.7 5.5 −1.7 3.5 AJH 1991; 4, 416–421.
W Gow 7 N 9 0 111 17 120 68 −8.0 1.6 −3.0 2.2 EJCP 1992; 43, 635–638.
W Cobiac 28 N 106 67 148 75 132 77 −2.8 1.6 −1.0 1.8 J. Hypertens 1992; 10, 87–92.
W Benetos 28 H 20 42 163 85 149 93 −6.5 1.9 −3.7 1.3 J. Hypertens, 1992; 10,
355–360.
W Sciarrone 56 TH 91 54 134 52 136 83 −5.8 4.1 −0.4 2.3 J. Hypertens 1992; 10, 287–298.
W Nestel 42 N 66 66 157 91 125 73 −3.2 2.7 −1.4 2.0 J. Hypertens 1993; 11,
1387–1394.
W Del Rio 14 H 30 49 199 48 156 96 −1.4 1.8 −0.5 1.3 JIM 1993; 233, 409–414.
W Zoccali 7 H 15 45 217 54 144 92 −14.0 2.5 −8.0 1.4 J. Hypertens. 1994; 12,
1249–1253.
W Jula 365 H 76 44 166 109 147 97 −6.7 3.9 −3.8 1.7 Circulation 1994; 89,
1023–1031.
W Howe 42 TH 56 55 158 78 145 81 −4.2 2.9 −1.5 1.9 J. Hum. Hyp. 1994; 8, 43–49.
W Miller 14 N 36 23 191 133 118 62 1.9 1.6 −0.1 1.5 Psychosom. Med. 1995; 57,
381–389.
W Fliser 7 N 7 26 203 23 114 71 −1.1 2.9 −0.7 1.8 EJCI 1995; 25, 39–43.
W Arrol 182 TH 181 55 122 106 145 89 −0.4 3.4 −1.2 2.1 NZ Med. J. 1995; 108, 266–268.
W Dubbert 90 TH 55 63 200 145 148 85 −1.4 3.8 −0.5 1.7 Behav. Ther. 1995; 26, 721–732.
W Grey 7 N 34 23 185 52 116 70 1.0 1.2 1.0 0.9 AJH 1996; 9, 317–322.
W Feldman H 7 H 8 27 182 6 126 79 2.6 2.9 1.6 1.8 CPT 1996; 60, 444–451.
W Schorr 28 N 16 64 166 105 140 84 −1.0 2.7 0.0 1.7 J. Hypertens 1996; 14, 131–135.
W Cappucio 30 N 18 67 167 91 149 85 −8.1 2.8 −3.9 1.5 Lancet 1997; 350, 850–854.
W van Buul 196 N 232 28 140 75 122 71 0.0 1.8 0.0 1.2 Hyp. Preg. 1997; 16, 335–346.
W Meland 56 H 16 50 191 125 146 95 −4.0 2.5 −3.0 1.4 SJCLI 1997; 57, 501–506.
W Feldman 7 N 8 33 207 48 130 82 0.0 5.5 0.0 3.6 AJH 1999; 12, 643–647.
W Barba 7 N 7 32 177 23 118 74 −3.2 5.5 −2.1 3.5 J. Hypertens. 2000; 18,
615–621.
W Sacks 30 N 54 49 141 64 129 84 −4.0 1.2 −1.4 0.8 NEJM 2001; 344, 3–10. AIM
2001; 135, 1019–1028.
W Sacks H 30 H 37 49 141 64 143 89 −6.6 1.2 −2.7 0.8 NEJM 2001; 344, 3-10. AIM
2001; 135, 1019–1028.
W Seals 90 H 35 64 132 86 143 78 −8.0 2.6 −2.0 1.7 J. Am. Coll. Cardiol. 2001; 38,
506–513.
W Appel TH 105 TH 471 66 145 105 128 71 −4.0 1.0 −1.6 0.7 Arch. IM 2001; 161, 685–693.
W Johnson 14 H 40 69 185 112 150 83 −4.5 2.1 −0.6 1.5 J. Hypertens. 2001; 19,
1053–1060.
W Manunta 14 H 20 48 177 67 152 99 −5.2 2.0 −3.3 2.0 Hypertension 2001; 38,
198–203.
W Kleij 7 N 27 24 236 50 119 74 0.2 3.3 0.1 2.1 JASN 2002; 13, 1025–1033.
W Kerstens 7 N 28 23 248 42 115 72 3.1 2.0 2.0 1.3 JCEM 2003; 88, 4180–4185.
W Nowson 28 N 92 45 139 51 123 75 −0.7 0.8 0.0 0.6 J. Nutr. 2003; 133, 4118–4123.
W Palacios 21 N 8 13 120 34 113 55 −0.1 1.5 4.2 1.7 JCEM 2004; 89, 1858–1863.
(Continued)
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TABLE 1 | Continued
Eth. Authors Dur. BP N Age HS LS B SBP B DBP E SBP SSE E DBP DSE References
W Gates 28 H 12 64 155 60 140 84 −3.0 1.8 −1.2 1.5 Hypertension 2004; 44, 35–41
W Damgaard 7 N 12 57 188 59 124 77 0.0 4.7 0.0 3.0 AJP RICP 2006; 290,
R1294–R1301.
W Melander 28 M 39 53 140 51 144 91 −6.0 1.2 −2.3 0.9 J. Hypertens. 2007; 25,
619–627.
W Dengel 8 H 28 63 191 36 152 79 −10.0 3.6 −4.0 3.6 Physiol. Res. 2007; 56,
393–401.
W Jessani 7 N 184 50 138 57 122 79 −1.0 0.8 −1.0 0.8 AJH 2008; 21: 1238–1244.
W Dickinson 14 N 29 53 156 64 116 73 −5.0 1.5 −1.0 1.1 AJCN 2009; 89, 485–490.
W He 42 H 71 52 165 110 146 90 −4.8 1.2 −2.2 0.7 Hypertension 2009; 54,
482–488.
W Meland 56 H 46 56 126 83 156 93 −5.0 3.8 −5.0 1.4 SJPHC 2009; 27, 97–103.
W Nowson TH 98 TH 35 59 113 69 130 80 −5.5 2.7 −3.6 1.6 Nutr. Res. 2009; 29, 8–18.
W Nowson 98 N 59 59 113 69 131 81 −1.1 2.0 0.3 1.5 Nutr. Res. 2009; 29, 8–18.
W Weir 28 H 132 52 208 85 139 87 −9.4 1.0 −5.7 0.7 J. Cardiovasc. PT 2010; 15,
356–363.
W Starmans-Kool 14 N 10 32 191 94 114 65 −2.0 3.4 0.0 3.4 J. Appl. Physiol. 2011; 110,
468–471.
Eth, Ethnicity; A, Asian; B, Black; W, White; NI, Nigeria; Ja, Jamaica; ANHMRC, Australian National Health and Medical Research Council; Dur, Duration (Days); BP, Blood pressure; H,
Hypertension; TH, Treated hypertension; N, Normotension; Age, Age (years); HS, High sodium intake (mmol); LS, Low sodium intake (mmol); B., Baseline; E, Effect; SBP, Systolic blood
pressure; DBP, Diastolic blood pressure; SSE, Systolic blood pressure standard error; DSE, Diastolic blood pressure standard error.
TABLE 2 | Baseline variables and blood pressure effects in populations of Whites, Blacks, and Asians balanced with respect to baseline blood pressure
unadjusted and adjusted for sodium reduction.
Asians (A) Blacks (B) Whites (W) W (A)* Significance
N studies 9 9 74 39
N participants 661 561 3782 2779
Female % 58 45 45 0.21
Mean (95% CI)
Sodium reduction (SR) mmol 97.89 [46.46,149.31] 63.16 [48.86,77.46] 102.91 [92.20,113.63] 66.12 [58.49,73.75] B vs. W 0.006
Age, years 52.30 [49.52,55.08] 46.83 [25.41,68.25] 43.04 [39.64,46.44] 49.14 [43.57,54.70] A vs. W: 0.03
Baseline SBP, mm Hg 138.29 [126.71,149.87] 132.84 [125.30,140.37] 133.58 [130.75,136.41] 137.24 [133.39,141.09] NS
Baseline DBP, mm Hg 84.68 [78.03,91.33] 80.90 [75.01,86.80] 80.69 [78.20,83.18] 82.43 [79.04,85.82] NS
Baseline sodium intake 217.48 [194.68,240.28] 148.70 [133.28,164.12] 167.67 [161.17,174.17] 137.43 [133.17,141.68] A vs. B and A vs. W: 0.00001
Effect SBP, mm Hg −3.83 [−6.35,−1.31] −4.68 [−7.10,−2.26] −3.24 [−4.01,−2.46] −3.06 [−3.94,−2.18] NS (Figure 1)
Effect DBP, mm Hg −1.99 [−3.04,−0.94] −2.99 [−3.95,−2.02] −1.54 [−2.05,−1.03] −1.51 [−2.04,−0.98] B vs. W: 0.04 B vs. W (A):
0.013 (Figure 1)
*Sodium reduction adjusted to Blacks by elimination of all studies of Whites with SR > 90mmol.
of baseline variables and BP effects of Asians, Blacks and Whites
are shown in Table 2. There was no statistical difference in sex
distribution although there was a trend toward a higher fraction
of females in Asians. Asians were significantly older and had a
significantly higher sodium intake than Blacks and Whites. Still
the effect of SR on SBP and DBP did not differ from the effect in
Blacks and Whites.
Figure 1 shows the comparisons between ethnic groups
of the summary measures of SBP and DBP. Cross-sectional
data for all included studies are shown in Figure 1, lines
1,3,5,8, 10, and 12. In addition the results from studies
investigating at least two ethnic groups are shown in
lines 2, 4, 6, 9, 11, and 13. The differences between
the ethnic groups are substantially smaller than in the
original analyses (Graudal et al., 2011). The effect of SR on
DBP showed a significant difference between Blacks and
Whites. The differences were generally smaller and not
statistically significant when comparing the data obtained
from studies investigating two or three ethnic groups in
identical studies (Figure 1, lines 2, 4, 6, 9, 11, and 13) than
when comparing data across studies (Figure 1, lines 1,3,5,8,
10, and 12).
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FIGURE 1 | Differences in effect of sodium reduction on systolic and diastolic blood pressure (SBP and DBP) between Asians (A), Blacks (B), and
Whites (W). E, Ethnic group; IS, Identical study.
TABLE 3 | Regressionkoefficient, mmHg (p-value) in univariate and multivariate regressionanalyses adjusted for additional confounders.
1: Ethnicity N = 92 (univariate) 2: 1 + Sodium reduction 3: 2 + Baseline blood
pressure
4: 3 + Age 5: 4 + Duration 6: 5 + Female%
Effect SBP, 1.28 (0.039) 1.32 (0.032) 1.15 (0.026) 1.08 (0.032) 1.12 (0.03) 1.07 (0.043)
Effect DBP, 0.63 (0.083) 0.60 (0.10) 0.50 (0.14) 0.46 (0.17) 0.55 (0.11) 0.61 (0.077)
Supplementary Analyzes
As the attempt to adjust the ethnic groups did not completely
succeed, we supplied with a supplementary meta-regression
analysis of ethnicity versus effect on blood pressure adjusted
for amount of sodium reduction, baseline blood pressure, age,
the duration of the sodium reduction intervention and the
female percentage. This analysis shows that there is a statistically
significant difference in SBP effect between the ethnic groups,
both unadjusted and adjusted, but clinically the difference is small
(about 1mmHg) (Table 3). There were no differences in DBP
effect between the ethnic groups (Table 3).
In another additional analysis we excluded 35 study
populations of Whites with a high sodium reduction to adjust
the quantity of sodium reduction in Blacks and Whites (Table 2,
column 5). This only changed the outcome blood pressures
marginally (Figure 1, lines 7 and 14).
Discussion
The present study, which attempted to adjust for baseline
blood pressure and the quantity of sodium reduction showed
that Asians had a non-significant trend toward a higher BP
response to SR than whites, but they were also older, had a
non-significantly higher mean baseline BP and a significantly
higher baseline sodium intake (Table 2). Blacks had a non-
significant trend toward a higher SBP response and a significant
trend toward a higher DBP response to SR than Whites while
matching the Whites on other baseline variables except quantity
of SR (Table 2). The difference was unchanged after adjusting
for quantity of SR (Table 2). The supplementary meta-regression
analyses adjusted for confounders confirmed that the ethnic
differences in blood pressure response to sodium reduction were
small, although marginally significant for SBP. Thus there may
be an unexplained additional effect of SR on BP, especially in
Blacks, which however is small compared to previous unadjusted
findings (Graudal et al., 2011). One explanation could be that
there are few studies in Asians and Blacks. Thismight increase the
risk of publication bias as suggested by our previous cumulative
meta-analysis (Graudal et al., 1998), which showed a higher
effect of SR on BP after publication of the first 7–8 studies,
whereas a smaller and more stable effect was manifest after
the publication of about 15 studies. This assumption is also
indicated by the fact that the comparisons of Asian, Black,
and White study populations from identical studies showed no
statistical differences between the ethnic groups (Figure 1). The
heterogeneity between the baseline characteristics was large and
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therefore it was difficult to adjust all 3 study-groups to identical
baseline values, because adjustment of one baseline value created
another imbalance between other baseline variables. However, in
spite of these variations, the differences in effects of SR on BP
between the ethnic groups were small.
Our results are in accordance with a recent co-operation
between Cuban, Canadian, and American researchers, who
compared Black and White Cubans living under similar socio-
economic conditions and found that “skin color was unrelated
to mean blood pressure or hypertensive status” (Ordúñez1 et al.,
2013). The background for this study was the assumption by
many scientists that the excess burden of hypertension among
blacks was an inevitable phenomenon. However, the authors
concluded that social conditions rather than ethnic group may
determine the general development of excess hypertension in
Blacks (Ordúñez1 et al., 2013). In that context it should be
emphasized that the sodium reduction RCTs of Whites generally
are performed in Europeans and Americans, whereas the RCTs
of Blacks are performed in Black Americans and Africans, who
socioeconomically are not comparable to White Americans and
Europeans. In that context it is interesting that after adjustment
for important confounders the difference between Whites and
Blacks was small. If we had been able to adjust for socio-economic
differences this last small difference in effect on DBP might have
disappeared.
The possibility that socioeconomic conditions has an
important influence on BP may also be reflected in the BP
development in the United States during the 20th century. Not
only did BP fall markedly in each new 10–year birth cohort from
1887 to 1975, the slope of the BP increase with age of each of
these cohorts also decreased (Goff et al., 2001). The total fall
in BP during the 20th century was dramatic and cannot solely
be explained by the introduction of antihypertensive treatments,
low-fat diets or decrease in the use of tobacco, as the BP fall
started long before these interventions. The enormous socio-
economic development in the United States is a muchmore likely
explanation. Recently the fall in BP seems to have stopped, maybe
due to the present overweight epidemic (Goff et al., 2012). In the
Cuban study the mean SBP was about 120mmHg (adults > 15
years) and the percentage of hypertension was about 31% in both
Blacks and Whites. In US the mean SBP was about 127mmHg
for Blacks and about 122mmHg for Whites (adults > 18 years)
(Wright et al., 2011). The percentage of hypertension is about
37% for Blacks and 30% for Whites (Wright et al., 2011).
An IOM report from 2004 recommended that all African
Americans eat less than 1500mg of sodium, whereas whites could
eat up to 2300mg of sodium (Institute of Medicine, 2004). In
contrast the recent IOM report from 2013 (Institute of Medicine,
2010) concluded “Given this background, overall, the committee
found that the available evidence on associations between sodium
intake and direct health outcomes is consistent with population-
based efforts to lower excessive dietary sodium intakes, but it is
not consistent with recommendations that encourage lowering
of dietary sodium in the general population to 1500mg per
day. Further, as noted in the 2010 DGAC report, population
subgroups, including those with diabetes, CKD, or preexisting
CVD, individuals with hypertension, pre-hypertension, persons
51 years of age and older, and African Americans represent,
in aggregate, a majority of the general U.S. population. Thus,
when considered in light of the current state of the evidence on
associations between sodium intake and direct health outcomes
for these subgroups, except when data specifically indicate
they are different, there is not sufficient evidence to support
treating them differently from the general U.S. population.”
The present study is in accordance with the 2013 IOM
conclusion indicating no true ethnic dependent sensitivity to
sodium.
In conclusion, ethnic differences in blood pressure response
to sodium reduction seem smaller than previously observed.
When the effect of SR on BP was adjusted for baseline blood
pressure and quantity of sodium reduction there was a small
statistically significant ethnic difference in SBP response and
DBP response depending on the statistical method used, but
the comparisons of Asian, Black and White study populations
from studies investigating ethnic groups in identical studies
showed no statistical differences in effect of SR on SBP or DBP
between the ethnic groups in accordance with the conclusion of
the 2013 IOM report. Whether the small observed differences
in the present study are due to socio-economic factors or
genetic factors remains to be setteled. Public guidelines like
the American Guidelines (U.S. Department of Agriculture and
U.S. Department of Health and Human Services 2010) might
be changed to recommend the same levels of sodium intake
irrespective of ethnicity.
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